BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 9, 2009
View Archived Issues
Roche Ups Offer for Genentech; Will $93 Per Share Get it Done?
After failing to tempt Genentech Inc.'s investors into tendering their shares for $86.50 a piece, Roche Holdings AG has upped its offer price to $93 per share. (BioWorld Today)
Read More
AEterna Partners with Sanofi in $165M Deal for BPH Drug
Read More
Surface Logix Gets $20M Series E, Starts Phase IIb in Dyslipidemia
Read More
Washington Actions Loaded with Implications for Biotech
Read More
Early Data Put Kibosh on Opko's Bevasiranib Trial
Read More
Appointments And Advancements
Read More
Clinic Roundup
Read More
Other News To Note
Read More